MicroRNA-650 Was a Prognostic Factor in Human Lung Adenocarcinoma and Confers the Docetaxel Chemoresistance of Lung Adenocarcinoma Cells via Regulating Bcl-2/Bax Expression
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-650 Was a Prognostic Factor in Human Lung Adenocarcinoma and Confers the Docetaxel Chemoresistance of Lung Adenocarcinoma Cells via Regulating Bcl-2/Bax Expression
Authors
Keywords
MicroRNAs, Protein expression, Apoptosis, Metastasis, Lymph nodes, Prognosis, Luciferase, MTT assay
Journal
PLoS One
Volume 8, Issue 8, Pages e72615
Publisher
Public Library of Science (PLoS)
Online
2013-08-22
DOI
10.1371/journal.pone.0072615
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNAs in autophagy and their emerging roles in crosstalk with apoptosis
- (2012) Jianzhen Xu et al. Autophagy
- MicroRNA-650 expression is influenced by immunoglobulin gene rearrangement and affects the biology of chronic lymphocytic leukemia
- (2012) M. Mraz et al. BLOOD
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- microRNA involvement in human cancer
- (2012) M. V. Iorio et al. CARCINOGENESIS
- Increased miR-708 Expression in NSCLC and Its Association with Poor Survival in Lung Adenocarcinoma from Never Smokers
- (2012) J. S. Jang et al. CLINICAL CANCER RESEARCH
- MicroRNAs in pancreas development
- (2012) O. Dumortier et al. DIABETES OBESITY & METABOLISM
- MicroRNAs: novel biomarkers for lung cancer diagnosis, prediction and treatment
- (2012) Qiming Wang et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Expression of tumor suppressor gene ING4 in ovarian carcinoma is correlated with microvessel density
- (2012) Yinglan Liu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- MicroRNA Expression Profiles of Whole Blood in Lung Adenocarcinoma
- (2012) Santosh K. Patnaik et al. PLoS One
- Down-regulation of NDRG2 gene expression in human colorectal cancer involves promoter methylation and microRNA-650
- (2011) Li Feng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3
- (2011) Bing Feng et al. CANCER
- MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1
- (2011) Bing Feng et al. CANCER LETTERS
- Experimental strategies for microRNA target identification
- (2011) D. W. Thomson et al. NUCLEIC ACIDS RESEARCH
- MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14)
- (2011) R Wang et al. ONCOGENE
- Downregulation and translocation of nuclear ING4 is correlated with tumorigenesis and progression of head and neck squamous cell carcinoma
- (2011) Xiao-han Li et al. ORAL ONCOLOGY
- Inhibitor of growth-4 mediates chromatin modification and has a suppressive effect on tumorigenesis and innate immunity
- (2011) Vivek Bhakta Mathema et al. TUMOR BIOLOGY
- MicroRNA-650 targets ING4 to promote gastric cancer tumorigenicity
- (2010) XueLi Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Down-regulation of ING4 is associated with initiation and progression of lung cancer
- (2010) Qiu-shi Wang et al. HISTOPATHOLOGY
- Identification of microRNA profiles in docetaxel-resistant human non-small cell lung carcinoma cells (SPC-A1)
- (2009) Wang Rui et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Reduced expression and novel splice variants ofING4in human gastric adenocarcinoma
- (2009) Ming Li et al. JOURNAL OF PATHOLOGY
- Progress in miRNA target prediction and identification
- (2009) Wei Xia et al. Science in China. Series C, Life sciences / Chinese Academy of Sciences
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started